Data / Companies / TWST
Twist Bioscience Corp.Nasdaq
TWST-US · CIK 0001581280 · Biological Products, (No Diagnostic Substances)
Revenue by quarter
US$ · last 8Hover a column for its exact figure
$0$50M$100M$150M
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
| Quarter | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $118.4M | -$35.1M | -0.56 |
| Q2 FY2026 | $110.7M | -$44.0M | -0.71 |
| Q1 FY2026 | $103.7M | -$30.5M | -0.50 |
| Q4 FY2025 | $99.0M | -$27.1M | -0.45 |
Newest filings
All 188| Form | Filed | |
|---|---|---|
| 8-K | 19 Aug 2026 | |
| 8-K | 19 Aug 2026 | |
| 8-K | 5 Aug 2026 | |
| 10-Q | 3 Aug 2026 | |
| 8-K | 3 Aug 2026 | |
| S-3ASR | 18 Jun 2026 | |
| 10-Q | 4 May 2026 | |
| 8-K | 4 May 2026 |
Description
- Ticker
- TWST-US
- Exchange
- Nasdaq
- Index
- –
- Industry
- Biological Products, (No Diagnostic Substances)
- SIC division
- Manufacturing
- CIK
- 0001581280
- Fiscal year ends
- Sep
- Filings held
- 188 since 2013
- 8-K events
- 81
- Shares short
- 10.2M, 15 Oct 2026
Financial statements
The main lines of the income statement, balance sheet and cash flow, by year and by quarter. Each period opens its filing.
5 years · US$ millions
| Fiscal period | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Period ending | 30 Sep 2021 | 30 Sep 2022 | 30 Sep 2023 | 30 Sep 2024 | 30 Sep 2025 |
| Reported in | 10-K | 10-K | 10-K | 10-K | 10-K |
| Report filed | 23 Nov 2021 | 28 Nov 2022 | 21 Nov 2023 | 18 Nov 2024 | 17 Nov 2025 |
| Revenue | 132M | 204M | 245M | 313M | 377M |
| Cost of revenue | 81M | 119M | 155M | 180M | 186M |
| Gross profit | 52M | 84M | 90M | 133M | 191M |
| Gross margin | 39.1% | 41.4% | 36.6% | 42.6% | 50.7% |
| Research and development | 69M | 120M | 107M | 91M | 80M |
| Selling, general and administrative | 136M | 213M | 190M | 218M | 247M |
| Operating income | -153M | -235M | -217M | -221M | -136M |
| Operating margin | -115.4% | -115.3% | -88.6% | -70.6% | -36.2% |
| Profit before tax | -154M | -228M | -203M | -208M | -77M |
| Income tax | -2M | -10M | 1M | 1M | 1M |
| Net income | -152M | -218M | -205M | -209M | -78M |
| Net margin | -114.9% | -107.0% | -83.5% | -66.7% | -20.6% |
| Earnings per share, diluted | -3.15 | -4.04 | -3.60 | -3.60 | -1.30 |
| Diluted shares | 48M | 54M | 57M | 58M | 60M |
Showing the last 5 years, FY2021 onwards. The full record goes back to FY2017 and comes with a data plan. Tell us what you need
Ratios
Worked out the same way for every company. Hover a ratio for how it is calculated.
Valuation
- Market cap
- $10.0B
- Price
- $159.87
- Price to book
- 22.48×
- Enterprise value
- $9.9B
- Market cap / sales
- 23.20×
- 52-week high
- $204.94
- 52-week low
- $25.45
Profitability
- Gross margin, TTM
- 52.0%
- Operating margin
- -33.6%
- Net margin
- -31.7%
- FCF margin
- -21.6%
- ROE
- -30.7%
- ROE, 3-year average
- -31.1%
- ROCE
- -31.5%
Growth
- Sales growth, TTM
- 19.2%
- Sales CAGR, 3 years
- 22.8%
- Sales CAGR, 5 years
- 33.1%
- Price, 1 year
- 367.7%
- Price CAGR, 3 years
- 119.5%
- Price CAGR, 5 years
- 5.6%
Balance sheet
- Cash and equivalents
- $117.4M
- Borrowings
- $15.0M
- Net debt
- -$102.4M
- Debt to equity
- 0.03×
- Shareholders' equity
- $445.7M
- Total assets
- $672.4M
- Net debt change, 1 year
- $83.9M
Shareholders
- Shares outstanding
- 62,674,000
- Share count, last 12 months
- 4.2%
- Years FCF margin > 20%, of 5
- 0
Showing the last 5 years, FY2021 onwards. The full record goes back to FY2017 and comes with a data plan. Tell us what you need
What the company said with its results
The key points, guidance and management's own words from each of the last four results releases.
No results summary read for this company yet.
Revenue by segment
As the company reports it in the segment note of each annual report: by business, by product and by region, latest year.
By product, FY2025
- NGS tools$208.1M 55.3%
- Synthetic genes$113.6M 30.2%
- Antibody discovery$23.5M 6.2%
- Oligo pools$20.2M 5.4%
- DNA libraries$11.2M 3.0%
3 years held, FY2023 to FY2025
By region, FY2025
- Americas$225.6M 59.9%
- EMEA$124.2M 33.0%
- APAC$26.8M 7.1%
3 years held, FY2023 to FY2025
Showing the last 5 years, FY2021 onwards. The full record goes back to FY2017 and comes with a data plan. Tell us what you need
Company events
Every 8-K, sorted by the event it reports, with the moment the SEC accepted it in New York time.
| 19 Aug 2026 | 8-K | Other events | 8.01, 9.01 | |
| 19 Aug 2026 | 8-K | Investor update | 7.01 | |
| 5 Aug 2026 | 8-K | Material agreementInvestor update | 1.01, 7.01, 9.01 | |
| 3 Aug 2026 | 8-K | Results | 2.02, 9.01 | |
| 4 May 2026 | 8-K | Results | 2.02, 9.01 | |
| 17 Feb 2026 | 8-K | Share saleOther events | 3.02, 8.01, 9.01 | |
| 6 Feb 2026 | 8-K | Shareholder vote | 5.07 | |
| 2 Feb 2026 | 8-K | Results | 2.02, 9.01 | |
| 12 Jan 2026 | 8-K | Results | 2.02, 9.01 | |
| 14 Nov 2025 | 8-K | Results | 2.02, 9.01 | |
| 6 Aug 2025 | 8-K | Leadership change | 5.02, 9.01 | |
| 4 Aug 2025 | 8-K | Results | 2.02, 9.01 | |
| 5 May 2025 | 8-K | ResultsMaterial agreementInvestor update | 1.01, 2.02, 7.01, 9.01 | |
| 11 Feb 2025 | 8-K | Leadership changeShareholder voteBylaws or fiscal year change | 5.02, 5.03, 5.07, 9.01 | |
| 3 Feb 2025 | 8-K | Results | 2.02, 9.01 | |
| 18 Nov 2024 | 8-K | Results | 2.02, 9.01 | |
| 15 Oct 2024 | 8-K | Leadership change | 5.02 | |
| 2 Aug 2024 | 8-K | Results | 2.02, 9.01 | |
| 2 May 2024 | 8-K | Results | 2.02, 9.01 | |
| 7 Feb 2024 | 8-K | Shareholder vote | 5.07 | |
| 2 Feb 2024 | 8-K | Results | 2.02, 9.01 | |
| 5 Jan 2024 | 8-K | Leadership changeInvestor update | 5.02, 7.01, 9.01 | |
| 17 Nov 2023 | 8-K | Results | 2.02, 9.01 | |
| 4 Aug 2023 | 8-K | ResultsLeadership change | 2.02, 5.02, 9.01 | |
| 4 Aug 2023 | 8-K/A | Restructuring | 2.05 | |
| 23 May 2023 | 8-K | Leadership change | 5.02, 9.01 | |
| 5 May 2023 | 8-K | ResultsRestructuring | 2.02, 2.05, 9.01 | |
| 28 Mar 2023 | 8-K | Leadership change | 5.02 | |
| 8 Feb 2023 | 8-K | Shareholder vote | 5.07 | |
| 3 Feb 2023 | 8-K | Results | 2.02, 9.01 | |
| 18 Nov 2022 | 8-K | Bylaws or fiscal year change | 5.03, 9.01 | |
| 18 Nov 2022 | 8-K | Results | 2.02, 9.01 | |
| 16 Nov 2022 | 8-K | Investor update | 7.01, 9.01 | |
| 26 Oct 2022 | 8-K | Leadership changeInvestor update | 5.02, 7.01, 9.01 | |
| 5 Aug 2022 | 8-K | Results | 2.02, 9.01 | |
| 5 May 2022 | 8-K | Results | 2.02, 9.01 | |
| 22 Apr 2022 | 8-K | Leadership changeInvestor update | 5.02, 7.01, 9.01 | |
| 9 Mar 2022 | 8-K | Auditor change | 4.01, 9.01 | |
| 15 Feb 2022 | 8-K | Material agreement | 1.01, 9.01 | |
| 9 Feb 2022 | 8-K | Shareholder vote | 5.07 | |
| 4 Feb 2022 | 8-K | Results | 2.02, 9.01 | |
| 2 Dec 2021 | 8-K | Other events | 8.01, 9.01 | |
| 23 Nov 2021 | 8-K/A | Leadership change | 5.02 | |
| 22 Nov 2021 | 8-K | Share sale | 3.02, 9.01 | |
| 22 Nov 2021 | 8-K | Results | 2.02, 9.01 | |
| 9 Aug 2021 | 8-K | Leadership change | 5.02, 9.01 | |
| 6 Aug 2021 | 8-K | Results | 2.02, 9.01 | |
| 30 Jun 2021 | 8-K | Other events | 8.01, 9.01 | |
| 6 May 2021 | 8-K | Results | 2.02, 9.01 | |
| 16 Apr 2021 | 8-K | Material agreement | 1.01, 9.01 |
1–50 of 81
8-K events each year
Hover a column for its exact count
051015
'18'22'26
Every filing
The company's filings with the SEC, newest first: 188 held. Insider, fund and large-holder filings have their own tables below.
| 19 Aug 2026 | 8-K | 19 Aug 2026 | |
| 19 Aug 2026 | 8-K | 18 Aug 2026 | |
| 5 Aug 2026 | 8-K | 4 Aug 2026 | |
| 3 Aug 2026 | 10-Q | 30 Jun 2026 | |
| 3 Aug 2026 | 8-K | 3 Aug 2026 | |
| 18 Jun 2026 | S-3ASR | – | |
| 4 May 2026 | 10-Q | 31 Mar 2026 | |
| 4 May 2026 | 8-K | 4 May 2026 | |
| 5 Mar 2026 | UPLOAD | – | |
| 26 Feb 2026 | CORRESP | – | |
| 26 Feb 2026 | 10-Q/A | 31 Dec 2025 | |
| 19 Feb 2026 | UPLOAD | – | |
| 17 Feb 2026 | 8-K | 11 Feb 2026 | |
| 6 Feb 2026 | 8-K | 5 Feb 2026 | |
| 2 Feb 2026 | 10-Q | 31 Dec 2025 | |
| 2 Feb 2026 | 8-K | 2 Feb 2026 | |
| 12 Jan 2026 | 8-K | 12 Jan 2026 | |
| 6 Jan 2026 | ARS | 30 Sep 2025 | |
| 6 Jan 2026 | DEF 14A | 5 Feb 2026 | |
| 17 Nov 2025 | 10-K | 30 Sep 2025 | |
| 14 Nov 2025 | 8-K | 14 Nov 2025 | |
| 6 Aug 2025 | 8-K | 5 Aug 2025 | |
| 4 Aug 2025 | 10-Q | 30 Jun 2025 | |
| 4 Aug 2025 | 8-K | 4 Aug 2025 | |
| 5 May 2025 | 10-Q | 31 Mar 2025 | |
| 5 May 2025 | 8-K | 2 May 2025 | |
| 12 Feb 2025 | S-8 | – | |
| 11 Feb 2025 | 8-K | 5 Feb 2025 | |
| 3 Feb 2025 | 10-Q | 31 Dec 2024 | |
| 3 Feb 2025 | 8-K | 3 Feb 2025 | |
| 6 Jan 2025 | ARS | 6 Jan 2025 | |
| 6 Jan 2025 | DEF 14A | 6 Jan 2025 | |
| 26 Dec 2024 | PRE 14A | 26 Dec 2024 | |
| 18 Nov 2024 | S-8 | – | |
| 18 Nov 2024 | 10-K | 30 Sep 2024 | |
| 18 Nov 2024 | 8-K | 18 Nov 2024 | |
| 15 Oct 2024 | 8-K | 8 Oct 2024 | |
| 2 Aug 2024 | 10-Q | 30 Jun 2024 | |
| 2 Aug 2024 | 8-K | 2 Aug 2024 | |
| 2 May 2024 | 10-Q | 31 Mar 2024 | |
| 2 May 2024 | 8-K | 2 May 2024 | |
| 7 Feb 2024 | 8-K | 6 Feb 2024 | |
| 2 Feb 2024 | 10-Q | 31 Dec 2023 | |
| 2 Feb 2024 | 8-K | 2 Feb 2024 | |
| 5 Jan 2024 | ARS | 30 Sep 2023 | |
| 5 Jan 2024 | DEF 14A | 6 Feb 2024 | |
| 5 Jan 2024 | 8-K | 5 Jan 2024 | |
| 21 Nov 2023 | S-8 | – | |
| 21 Nov 2023 | 10-K | 30 Sep 2023 | |
| 17 Nov 2023 | 8-K | 17 Nov 2023 |
1–50 of 150
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months, with the shares they held after.
| 23 Oct 2026 | Finn Patrick JohnPresident and COO | Sale outside a trading plan | 2,245 | $134.59 | $302.2K | 182,843 | 27 Oct 2026 |
| 9 Oct 2026 | Laponis AdamChief Financial Officer | Sale outside a trading plan | 2,462 | $156.30 | $384.8K | 98,114 | 13 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 1,840 | $200.44 | $368.8K | 565,468 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 481 | $201.26 | $96.8K | 564,987 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 1,017 | $202.32 | $205.8K | 563,970 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 432 | $203.61 | $88.0K | 563,538 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 290 | $204.80 | $59.4K | 563,248 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 297 | $205.78 | $61.1K | 562,951 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 146 | $206.84 | $30.2K | 562,805 | 7 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 45 | $207.46 | $9.3K | 562,760 | 7 Oct 2026 |
| 2 Oct 2026 | Laponis AdamChief Financial Officer | Sale outside a trading plan | 8,057 | $188.88 | $1.5M | 100,576 | 5 Oct 2026 |
| 2 Oct 2026 | Green PaulaSVP of Human Resources | Sale outside a trading plan | 10,088 | $188.88 | $1.9M | 106,632 | 5 Oct 2026 |
| 2 Oct 2026 | Finn Patrick JohnPresident and COO | Sale outside a trading plan | 25,714 | $188.88 | $4.9M | 185,088 | 5 Oct 2026 |
| 2 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 45,736 | $188.88 | $8.6M | 567,308 | 5 Oct 2026 |
| 2 Oct 2026 | Cho DennisSee Remarks | Sale outside a trading plan | 9,514 | $188.88 | $1.8M | 63,789 | 5 Oct 2026 |
| 2 Oct 2026 | Werner Robert F.Chief Accounting Officer | Sale outside a trading plan | 1,482 | $188.88 | $279.9K | 42,917 | 5 Oct 2026 |
| 1 Oct 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 655 | $200.00 | $131.0K | 613,044 | 5 Oct 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 2,485 | $175.23 | $435.4K | 616,417 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 945 | $176.39 | $166.7K | 615,472 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 164 | $177.17 | $29.1K | 615,308 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 330 | $178.67 | $59.0K | 614,978 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 143 | $179.93 | $25.7K | 614,835 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 515 | $180.39 | $92.9K | 614,320 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 21 | $181.45 | $3.8K | 614,299 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 16 | $182.50 | $2.9K | 614,283 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 501 | $183.76 | $92.1K | 613,782 | 25 Sep 2026 |
| 24 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 83 | $184.60 | $15.3K | 613,699 | 25 Sep 2026 |
| 21 Sep 2026 | Cho DennisSee Remarks | Sale outside a trading plan | 348 | $165.49 | $57.6K | 73,303 | 23 Sep 2026 |
| 21 Sep 2026 | Green PaulaSVP of Human Resources | Sale outside a trading plan | 294 | $165.49 | $48.7K | 116,720 | 23 Sep 2026 |
| 21 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale outside a trading plan | 1,687 | $165.49 | $279.2K | 618,902 | 23 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 2,440 | $151.46 | $369.6K | 974,695 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 6,644 | $152.21 | $1.0M | 968,051 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 3,399 | $153.40 | $521.4K | 964,652 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 4,175 | $154.17 | $643.7K | 960,477 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 13,378 | $155.46 | $2.1M | 947,099 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 9,097 | $156.47 | $1.4M | 938,002 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 32,260 | $157.49 | $5.1M | 905,742 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 232,173 | $158.09 | $36.7M | 673,569 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 23,884 | $159.53 | $3.8M | 649,685 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 14,493 | $160.44 | $2.3M | 635,192 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 11,169 | $161.49 | $1.8M | 624,023 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 2,565 | $162.31 | $416.3K | 621,458 | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 869 | $163.39 | $142.0K | 620,589 | 21 Sep 2026 |
| 8 Sep 2026 | Cho DennisSee Remarks | Sale outside a trading plan | 412 | $122.62 | $50.5K | 73,651 | 10 Sep 2026 |
| 8 Sep 2026 | Green PaulaSVP of Human Resources | Sale outside a trading plan | 907 | $122.62 | $111.2K | 117,014 | 10 Sep 2026 |
| 8 Sep 2026 | Leproust Emily M.Chief Executive Officer | Sale outside a trading plan | 2,302 | $122.62 | $282.3K | 768,427 | 10 Sep 2026 |
| 8 Sep 2026 | Werner Robert F.Chief Accounting Officer | Sale outside a trading plan | 238 | $122.62 | $29.2K | 44,399 | 10 Sep 2026 |
| 25 Aug 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 12,648 | $150.56 | $1.9M | 799,651 | 27 Aug 2026 |
| 25 Aug 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 12,236 | $151.35 | $1.9M | 787,415 | 27 Aug 2026 |
| 25 Aug 2026 | Leproust Emily M.Chief Executive Officer | Sale under a trading plan | 6,412 | $152.75 | $979.4K | 781,003 | 27 Aug 2026 |
1–50 of 150
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| 23 Oct 2026 | Finn Patrick JohnOfficer | 2,245 | $302.2K | 23 Oct 2026 |
| 9 Oct 2026 | Laponis AdamOfficer | 2,462 | $384.8K | 9 Oct 2026 |
| 5 Oct 2026 | Leproust Emily M.Officer, Director | 4,548 | $919.4K | 5 Oct 2026 |
| 2 Oct 2026 | WERNER ROBERT F.Officer | 1,482 | $279.9K | 2 Oct 2026 |
| 2 Oct 2026 | Laponis AdamOfficer | 8,057 | $1.5M | 2 Oct 2026 |
| 2 Oct 2026 | Cho DennisOfficer | 9,514 | $1.8M | 2 Oct 2026 |
| 2 Oct 2026 | Green PaulaOfficer | 10,088 | $1.9M | 2 Oct 2026 |
| 2 Oct 2026 | Finn Patrick JohnOfficer | 25,714 | $4.9M | 2 Oct 2026 |
| 2 Oct 2026 | Leproust Emily M.Officer, Director | 45,736 | $8.6M | 2 Oct 2026 |
| 1 Oct 2026 | Leproust Emily M.Officer, Director | 655 | $131.0K | 1 Oct 2026 |
| 24 Sep 2026 | Leproust Emily M.Officer, Director | 5,203 | $922.9K | 24 Sep 2026 |
| 21 Sep 2026 | Green PaulaOfficer | 294 | $48.7K | 21 Sep 2026 |
| 21 Sep 2026 | Cho DennisOfficer | 348 | $57.6K | 21 Sep 2026 |
| 21 Sep 2026 | Leproust Emily M.Officer, Director | 1,687 | $279.2K | 21 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Officer, Director | 61,509 | $9.3M | 17 Sep 2026 |
| 17 Sep 2026 | Leproust Emily M.Officer, Director | 295,037 | $44.7M | 17 Sep 2026 |
| 8 Sep 2026 | WERNER ROBERT F.Officer | 238 | $29.2K | 8 Sep 2026 |
| 8 Sep 2026 | Cho DennisOfficer | 412 | $50.5K | 8 Sep 2026 |
| 8 Sep 2026 | Green PaulaOfficer | 907 | $111.2K | 8 Sep 2026 |
| 8 Sep 2026 | Leproust Emily M.Officer, Director | 2,302 | $282.3K | 8 Sep 2026 |
| 25 Aug 2026 | Leproust Emily M.Officer, Director | 41,570 | $6.3M | 25 Aug 2026 |
| 24 Aug 2026 | WERNER ROBERT F.Officer | 854 | $120.2K | 24 Aug 2026 |
| 21 Aug 2026 | WERNER ROBERT F.Officer | 669 | $93.0K | 21 Aug 2026 |
| 21 Aug 2026 | Green PaulaOfficer | 1,360 | $189.1K | 21 Aug 2026 |
| 21 Aug 2026 | Cho DennisOfficer | 1,598 | $222.2K | 21 Aug 2026 |
| 21 Aug 2026 | Laponis AdamOfficer | 1,965 | $273.3K | 21 Aug 2026 |
| 21 Aug 2026 | Finn Patrick JohnOfficer | 4,046 | $562.7K | 21 Aug 2026 |
| 21 Aug 2026 | Leproust Emily M.Officer, Director | 6,639 | $923.3K | 21 Aug 2026 |
| 19 Aug 2026 | Cho DennisOfficer | 14,205 | $1.8M | 19 Aug 2026 |
| 18 Aug 2026 | Finn Patrick JohnOfficer | 78,355 | $9.5M | 18 Aug 2026 |
| 12 Aug 2026 | BLAKE KATRYNDirector | 2,240 | $275.3K | 12 Aug 2026 |
| 12 Aug 2026 | Leproust Emily M.Officer, Director | 19,952 | $2.5M | 12 Aug 2026 |
| 10 Aug 2026 | Leproust Emily M.Officer, Director | 113,318 | $14.2M | 10 Aug 2026 |
| 7 Aug 2026 | CHESS ROBERTDirector | 18,417 | $2.0M | 7 Aug 2026 |
| 5 Aug 2026 | Cho DennisOfficer | 14,205 | $1.6M | 5 Aug 2026 |
| 3 Aug 2026 | WERNER ROBERT F.Officer | 167 | $14.2K | 3 Aug 2026 |
| 3 Aug 2026 | Cho DennisOfficer | 1,070 | $91.3K | 3 Aug 2026 |
| 3 Aug 2026 | Green PaulaOfficer | 1,133 | $96.7K | 3 Aug 2026 |
| 3 Aug 2026 | Finn Patrick JohnOfficer | 2,888 | $246.4K | 3 Aug 2026 |
| 3 Aug 2026 | Leproust Emily M.Officer, Director | 5,101 | $435.2K | 3 Aug 2026 |
| 23 Jul 2026 | Finn Patrick JohnOfficer | 2,238 | $210.1K | 23 Jul 2026 |
| 9 Jul 2026 | Laponis AdamOfficer | 2,399 | $226.3K | 9 Jul 2026 |
| 25 Jun 2026 | Leproust Emily M.Officer, Director | 18,880 | $1.8M | 25 Jun 2026 |
| 24 Jun 2026 | Cho DennisOfficer | 14,205 | $1.3M | 24 Jun 2026 |
| 22 Jun 2026 | Green PaulaOfficer | 291 | $25.4K | 22 Jun 2026 |
| 22 Jun 2026 | Cho DennisOfficer | 346 | $30.2K | 22 Jun 2026 |
| 22 Jun 2026 | Leproust Emily M.Officer, Director | 1,688 | $147.4K | 22 Jun 2026 |
| 15 Jun 2026 | Green PaulaOfficer | 26,137 | $2.1M | 15 Jun 2026 |
| 8 Jun 2026 | WERNER ROBERT F.Officer | 232 | $16.2K | 8 Jun 2026 |
| 8 Jun 2026 | Cho DennisOfficer | 402 | $28.1K | 8 Jun 2026 |
1–50 of 80
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| 8 Sep 2026 | ARK Investment Management LLC | 13G amended | 5.11% | 3.4M |
| 8 Sep 2026 | FMR LLC | 13G amended | 13.2% | 8.8M |
| 14 Aug 2026 | EdgePoint Investment Group Inc. | 13G amended | 4.21% | 2.5M |
| 14 Aug 2026 | ARK Investment Management LLC | 13G amended | 7.31% | 4.5M |
| 14 Aug 2026 | T. Rowe Price Associates, Inc. | 13G | 5.8% | 3.6M |
| 13 Aug 2026 | Artisan Partners Asset Management Inc. | 13G amended | 7.7% | 4.8M |
| 11 Aug 2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G amended | 3.5% | 2.2M |
| 6 Aug 2026 | FMR LLC | 13G | 7.6% | 4.7M |
| 7 May 2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G amended | 8.6% | 5.3M |
| 30 Apr 2026 | Vanguard Capital Management | 13G | 5.05% | 3.1M |
| 30 Apr 2026 | ARK Investment Management LLC | 13G amended | 10.35% | 6.3M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 6 Mar 2026 | Artisan Partners Asset Management Inc. | 13G amended | 10.1% | 6.2M |
| 17 Feb 2026 | EdgePoint Investment Group Inc. | 13G amended | 8.8% | 5.4M |
| 9 Feb 2026 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G amended | 9.7% | 6.0M |
| 3 Feb 2026 | Artisan Partners Asset Management Inc. | 13G amended | 9.5% | 5.8M |
| 3 Feb 2026 | ARK Investment Management LLC | 13G amended | 12.36% | 7.6M |
| 14 Nov 2025 | EdgePoint Investment Group Inc. | 13G | 6.76% | 4.1M |
| 10 Nov 2025 | STATE STREET CORPORATION | 13G | 5.1% | 3.1M |
Trades by members of the House
From each member's periodic transaction report: the amount is the band the report gives.
| 30 Mar 2022 | Dwight EvansPA03 | Sale | $1,001 - $15,000 | Self | 25 Apr 2022 |
| 2 Mar 2020 | Dwight EvansPA03 | Purchase | $1,001 - $15,000 | Self | 23 Apr 2020 |
Short interest
Shares sold short and not yet bought back, on every FINRA settlement date.
Shares short, each settlement
| 15 Oct 2026 | 10.2M | -3.4% | 2.82 |
| 30 Sep 2026 | 10.6M | -15.5% | 3.83 |
| 15 Sep 2026 | 12.5M | +3.65% | 8.92 |
| 31 Aug 2026 | 12.1M | -14.49% | 6.91 |
| 14 Aug 2026 | 14.1M | +0.24% | 7.9 |
| 31 Jul 2026 | 14.1M | -0.29% | 11.12 |
| 15 Jul 2026 | 14.1M | +1.19% | 9.69 |
| 30 Jun 2026 | 13.9M | -21.01% | 5.51 |
| 15 Jun 2026 | 17.7M | +18.54% | 9.58 |
| 29 May 2026 | 14.9M | -10.13% | 8.99 |
1–10 of 144
Funds that hold it
Every fund's holding from its latest Form 13F, largest first, with what it added or trimmed in the quarter.
Funds holding
368
quarter to 30 Jun 2026
Added or new
184
since 31 Mar 2026
Trimmed
101
in the quarter
Largest holder
BlackRock, Inc.
$600.2M
The 60 largest of 368 funds, by value
| BlackRock, Inc. | $600.2M | 5.8M | +279.5K | Added | 0.01% | Filing ↗ |
| Artisan Partners Limited Partnership | $494.0M | 4.8M | -1.6M | Trimmed | 0.81% | Filing ↗ |
| FMR LLC | $483.8M | 4.7M | +2.8M | Added | 0.02% | Filing ↗ |
| ARK Investment Management LLC | $468.1M | 4.5M | -1.8M | Trimmed | 3.04% | Filing ↗ |
| Price T Rowe Associates Inc. | $373.9M | 3.6M | +3.6M | Added | 0.04% | Filing ↗ |
| State Street Corp. | $332.6M | 3.2M | -438.1K | Trimmed | 0.01% | Filing ↗ |
| Vanguard Portfolio Management LLC | $290.6M | 2.8M | +175.9K | Added | 0.01% | Filing ↗ |
| Vanguard Capital Management LLC | $277.7M | 2.7M | +60.2K | Added | 0.01% | Filing ↗ |
| EdgePoint Investment Group Inc. | $259.4M | 2.5M | -2.9M | Trimmed | 1.96% | Filing ↗ |
| William Blair Investment Management, LLC | $223.7M | 2.2M | -3.1M | Trimmed | 0.67% | Filing ↗ |
| Farallon Capital Management, L.l.c. | $219.8M | 2.1M | +708.8K | Added | 1.30% | Filing ↗ |
| Invesco Ltd. | $198.4M | 1.9M | -243.7K | Trimmed | 0.02% | Filing ↗ |
| Geode Capital Management, LLC | $166.6M | 1.6M | +99.6K | Added | 0.01% | Filing ↗ |
| Thrivent Financial for Lutherans | $147.5M | 1.4M | +121.0K | Added | 0.25% | Filing ↗ |
| Goldman Sachs Group Inc. | $144.9M | 1.4M | -297.1K | Trimmed | 0.01% | Filing ↗ |
| Morgan Stanley | $122.4M | 1.2M | +643.0K | Added | 0.01% | Filing ↗ |
| D. E. Shaw & Co., Inc. | $122.0M | 1.2M | +1.1M | Added | 0.08% | Filing ↗ |
| Baillie Gifford & Co. | $111.8M | 1.1M | -128.4K | Trimmed | 0.10% | Filing ↗ |
| Driehaus Capital Management LLC | $105.2M | 1.0M | +437.8K | Added | 0.61% | Filing ↗ |
| Sumitomo Mitsui Trust Group, Inc. | $102.9M | 1.0M | -495.8K | Trimmed | 0.06% | Filing ↗ |
| Amova Asset Management Americas, Inc. | $102.8M | 999.7K | -496.4K | Trimmed | 1.33% | Filing ↗ |
| Bank of America Corp. | $94.9M | 922.6K | +338.4K | Added | 0.01% | Filing ↗ |
| Citadel Advisors LLC | $88.7M | 862.0K | -358.4K | Trimmed | 0.05% | Filing ↗ |
| Loomis Sayles & Co. L P | $88.6M | 861.3K | +369.0K | Added | 0.11% | Filing ↗ |
| Stephens Investment Management Group LLC | $78.9M | 767.4K | +767.4K | New | 0.85% | Filing ↗ |
| First Light Asset Management, LLC | $74.9M | 727.9K | -150.9K | Trimmed | 4.55% | Filing ↗ |
| Voya Investment Management LLC | $69.1M | 671.9K | +661.5K | Added | 0.07% | Filing ↗ |
| FIL Ltd | $66.0M | 641.1K | +641.1K | New | 0.05% | Filing ↗ |
| T. Rowe Price Investment Management, Inc. | $61.5M | 597.9K | +597.9K | New | 0.04% | Filing ↗ |
| Northern Trust Corp. | $60.9M | 591.7K | +63.7K | Added | 0.01% | Filing ↗ |
| Dimensional Fund Advisors LP | $59.9M | 582.7K | -198.9K | Trimmed | 0.01% | Filing ↗ |
| Wellington Management Group LLP | $58.5M | 568.3K | -170.3K | Trimmed | 0.01% | Filing ↗ |
| UBS AM, a distinct business unit of UBS Asset Management Americas LLC | $58.0M | 563.8K | -260.2K | Trimmed | 0.01% | Filing ↗ |
| Fred Alger Management, LLC | $57.4M | 558.2K | +462.4K | Added | 0.19% | Filing ↗ |
| Charles Schwab Investment Management Inc. | $57.3M | 557.1K | +20.0K | Added | 0.01% | Filing ↗ |
| BNP Paribas Financial Markets | $56.2M | 546.6K | -57.4K | Trimmed | 0.03% | Filing ↗ |
| Nuveen, LLC | $53.7M | 522.0K | +228.4K | Added | 0.01% | Filing ↗ |
| American Century Companies Inc. | $50.1M | 487.0K | +449.2K | Added | 0.02% | Filing ↗ |
| Tao Capital Management LP | $49.3M | 478.8K | -350.0K | Trimmed | 2.54% | Filing ↗ |
| New York State Common Retirement Fund | $47.5M | 462.1K | -211.8K | Trimmed | 0.06% | Filing ↗ |
| Jennison Associates LLC | $46.6M | 453.2K | -152.0K | Trimmed | 0.03% | Filing ↗ |
| Vanguard Fiduciary Trust Co. | $45.6M | 443.5K | +20.4K | Added | 0.01% | Filing ↗ |
| Allspring Global Investments Holdings, LLC | $42.8M | 418.1K | -37.3K | Trimmed | 0.07% | Filing ↗ |
| UBS Group AG | $42.5M | 413.1K | -39.4K | Trimmed | 0.01% | Filing ↗ |
| Marshall Wace, LLP | $40.8M | 396.9K | +396.9K | New | 0.04% | Filing ↗ |
| Millennium Management LLC | $35.7M | 347.1K | -3.5K | Trimmed | 0.03% | Filing ↗ |
| Ameriprise Financial Inc. | $35.0M | 340.1K | +306.8K | Added | 0.01% | Filing ↗ |
| Granahan Investment Management, LLC | $32.4M | 314.9K | +314.9K | New | 1.15% | Filing ↗ |
| Lord, Abbett & Co. LLC | $30.8M | 299.3K | +199.6K | Added | 0.09% | Filing ↗ |
| Federated Hermes, Inc. | $30.7M | 298.1K | +298.1K | New | 0.04% | Filing ↗ |
1–50 of 60
Dividends and buybacks
Dividend per share, the cash paid and the shares bought back, each fiscal year.
This company has paid no dividend in the years held.
Peers
Companies in the same industry, largest first, on the same measures.
| Company | Market value | Revenue, 12 months | Revenue growth | Operating margin | Net margin | ROE | P/E | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp.this company | $10.0B | $431.8M | 19.2% | -33.6% | -31.7% | -30.7% | – | – |
| Amgen Inc. | $242.2B | $38.1B | 9.1% | 30.0% | 23.0% | 74.8% | 27.8× | 20.2× |
| Gilead Sciences, Inc. | $197.4B | $30.5B | 5.5% | -8.2% | -10.6% | -27.4% | – | – |
| Moderna, Inc. | $82.9B | $2.2B | -27.6% | -149.0% | -141.4% | -46.6% | – | – |
| argenx SE | $54.6B | $4.2B | 89.9% | – | – | 17.6% | 45.1× | – |
| Biogen Inc. | $37.3B | $10.0B | 0.3% | 10.1% | 8.3% | 4.4% | 44.7× | 23.8× |
| BioNTech SE | $21.9B | $3.2B | 4.3% | -49.0% | -39.6% | -5.9% | – | – |
| Exelixis, Inc. | $16.3B | $2.4B | 9.2% | 39.9% | 35.3% | 46.7% | 20.6× | 16.0× |
| Neurocrine Biosciences Inc. | $14.8B | $3.4B | 34.4% | 23.6% | 20.9% | 19.1% | 21.4× | 17.2× |
| Halozyme Therapeutics, Inc. | $14.7B | $1.7B | 41.2% | 35.9% | 24.9% | 288.1% | 38.4× | 27.2× |
| Bio-Techne Corp. | $11.3B | $1.2B | -0.4% | 20.7% | 15.0% | 8.6% | 63.1× | 32.3× |
What the company does
The description for this company is being written.
Free for your personal research, with credit and a link. For API access, bulk files or commercial use, tell us what you need. The data licence